New Research Initiatives Dana-Farber Cancer Institute has launched several new research studies, including identifying biomarkers for renal cell carcinoma and establishing Centers for Early Detection and Interception. These initiatives present opportunities for collaboration with pharmaceutical companies and diagnostic firms looking to partner in cutting-edge cancer research.
Partnership Opportunities The recent launch of the Direct Connect Partnership with Massachusetts Firefighters and collaborations with eFFECTOR Therapeutics and the Professional Fire Fighters of Massachusetts highlight Dana-Farber's commitment to partnerships. This opens avenues for companies specializing in oncology treatments or health tech solutions to explore potential partnerships with the institute.
Key Leadership Appointment The appointment of Joel T. Katz as Senior Vice President for Education signifies a strategic move to enhance educational programs at Dana-Farber Cancer Institute. Educational service providers and training institutions could explore opportunities to offer specialized educational services to the institute under Katz's leadership.
Industry Recognition Securing a substantial funding of $51 million in seed financing reflects industry recognition of Dana-Farber's impactful work in cancer research and patient care. This achievement can be leveraged by companies in the biotech or healthcare sector as a testament to Dana-Farber's credibility and potential partnership value.
Clinical Trial Collaborations The partnership for an investigator-sponsored Phase 2 clinical trial with eFFECTOR Therapeutics presents an opportunity for companies in the pharmaceutical industry to explore collaboration on clinical trials and drug development. This collaboration showcases Dana-Farber's role in advancing novel treatments for cancer patients.
Dana-Farber Cancer Institute uses 8 technology products and services including Lucidchart, Ektron CMS, OneTrust, and more. Explore Dana-Farber Cancer Institute's tech stack below.
| Dana-Farber Cancer Institute Email Formats | Percentage |
| first_last@dfci.harvard.edu | 90% |
| last_first@dfci.harvard.edu | 8% |
| first.last@dfci.harvard.edu | 1% |
| last@dfci.harvard.edu | 0% |
| first_l@dfci.harvard.edu | 1% |
| flast@dfci.harvard.edu | 0% |
| f_last@dfci.harvard.edu | 0% |
| first.l@dfci.harvard.edu | 0% |
| flast@partners.org | 93% |
| lfirst@partners.org | 2% |
| filast@partners.org | 1% |
| fmlast@partners.org | 0% |
| firstlast@partners.org | 1% |
| first.last@partners.org | 1% |
| fmiddlelast@partners.org | 0% |
| last@partners.org | 1% |
| lastf@partners.org | 0% |
| firstl@partners.org | 0% |
| f.last@partners.org | 0% |
| first@partners.org | 0% |
| first_last@partners.org | 1% |
| fl@partners.org | 0% |
| lastfirst@partners.org | 0% |
| lastfi@partners.org | 0% |
| firstla@partners.org | 0% |
| firlast@partners.org | 0% |
| lastfir@partners.org | 0% |
| lf@partners.org | 0% |
| firstmiddlelast@partners.org | 0% |
| firstlas@partners.org | 0% |
| first.middle@partners.org | 0% |
| middle@partners.org | 0% |
| first.middle.last@partners.org | 0% |
| f-last@partners.org | 0% |
| first.last@dana-farber.org | 86% |
| last@dana-farber.org | 12% |
| flast@dana-farber.org | 1% |
| first_last@dana-farber.org | 1% |
Hospitals and Health CareMassachusetts, United States1001-5000 Employees
Dana-Farber Cancer Institute is committed to providing expert, compassionate care to children and adults with cancer, while advancing the understanding, treatment, cure, and prevention of cancer and related diseases.
Company Overview
Media & News
Funding & FinancialsDana-Farber Cancer Institute has raised a total of $300K of funding over 5 rounds. Their latest funding round was raised on Sep 27, 2022.
Dana-Farber Cancer Institute's revenue is in the range of $1B
Funding & FinancialsDana-Farber Cancer Institute has raised a total of $300K of funding over 5 rounds. Their latest funding round was raised on Sep 27, 2022.
Dana-Farber Cancer Institute's revenue is in the range of $1B
Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.
1-888-653-2347 
support@leadiq.com